Literature DB >> 31291522

Improving Treatment for Advanced Prostate Cancer.

Ian F Tannock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31291522     DOI： 10.1056/NEJMe1906363

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review.

Authors:  Shruti Parshad; Amanjot K Sidhu; Nabeeha Khan; Andrew Naoum; Urban Emmenegger
Journal:  J Clin Med       Date:  2022-05-15       Impact factor: 4.964

2.  Low-Dose Abiraterone, a Rare European Commodity.

Authors:  Niamh Peters; Mohammed Zeeshan Zameer; Seamus O'Reilly
Journal:  JCO Glob Oncol       Date:  2020-05

3.  Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation.

Authors:  Jingjing Wu; Shundong Cang; Christina Liu; Whitman Ochiai; Jen Wei Chiao
Journal:  Exp Hematol Oncol       Date:  2020-06-11

4.  Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.

Authors:  Geetha Nalairndran; Ivy Chung; Azad Hassan Abdul Razack; Felicia Fei-Lei Chung; Ling-Wei Hii; Wei-Meng Lim; Chin King Looi; Chun-Wai Mai; Chee-Onn Leong
Journal:  J Cell Mol Med       Date:  2021-07-28       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.